| Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies A Mahmoud, A Mostafa, AA Al-Karmalawy, A Zidan, HS Abulkhair, ... Heliyon 7 (9), 2021 | 79 | 2021 |
| PHARMIP: An insilico method to predict genetics that underpin adverse drug reactions AM Zidan, EA Saad, NE Ibrahim, A Mahmoud, MH Hashem, AA Hemeida MethodsX 7, 100775, 2020 | 9 | 2020 |
| Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies. Heliyon 7: e07962 A Mahmoud, A Mostafa, AA Al-Karmalawy, A Zidan, HS Abulkhair, ... | 5 | 2021 |
| GSK3B Prediction as primary cellular target to mediate the anti-HCV effect of Nitazoxanide AM Zidan, AA Hemeida, AM Hussein, MH Hashem INTERNATIONAL RESEARCH JOURNAL OF PHARMACY, 2013 | 4 | 2013 |
| Host pharmacogenetic factors that may affect liver neoplasm incidence upon using direct-acting antivirals for treating hepatitis C infection AM Zidan, EA Saad, NE Ibrahim, MH Hashem, A Mahmoud, AA Hemeida Heliyon 7 (5), 2021 | 3 | 2021 |
| COMPUTATIONAL PREDICTION OF THE PROTEIN KINASE THAT MEDIATESTHE ANTI-HCV EFFECT OF NITAZOXANIDE AM ZIDAN University of Sadat City, 2014 | 1 | 2014 |
| BIOINFORMATICS IN PERSONALIZED MEDICINE: CLINICAL ANALYSIS OF PERSONAL GENETIC DATA AM ZIDAN University of Sadat City, 2021 | | 2021 |
| HCV DAAs & HCC https://data.mendeley.com/datasets/8ws8258hn3/2, 0 | | |
Alaa A. HemeidaProfessor of molecular Genetics,Universty of sadat cityVerified email at gebri.usc.edu.eg